Winslow Evans & Crocker’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Winslow Evans & Crocker’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$15K	Hold	197	–	–	﹤0.01%	870
2020 Q3	$15K	Hold	197	–	–	﹤0.01%	676
2020 Q2	$12K	Buy	197 +41	+26%	+$2.26K	﹤0.01%	713
2020 Q1	$8K	Hold	156	–	–	﹤0.01%	783
2019 Q4	$8K	Hold	156	–	–	﹤0.01%	905
2019 Q3	$8K	Buy	156 +86	+123%	+$4.83K	﹤0.01%	886
2019 Q2	$6K	Hold	70	–	–	﹤0.01%	969
2019 Q1	$4K	Hold	70	–	–	﹤0.01%	1073
2018 Q4	$4K	Hold	70	–	–	﹤0.01%	985
2018 Q3	$4K	Hold	70	–	–	﹤0.01%	990
2018 Q2	$4K	Hold	70	–	–	﹤0.01%	1002
2018 Q1	$2.77K	Hold	70	–	–	﹤0.01%	981
2017 Q4	$2.38K	Hold	70	–	–	﹤0.01%	1018
2017 Q3	$1.79K	Hold	70	–	–	﹤0.01%	1038
2017 Q2	$1.18K	Hold	70	–	–	﹤0.01%	1204
2017 Q1	$1.02K	Buy	+70	New	+$1.04K	﹤0.01%	1186

Other funds holding ARNA

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Winslow Evans & Crocker's ARNA Position: Q4 2020 in Review

Winslow Evans & Crocker held its Arena Pharmaceuticals Inc (ARNA) position steady in Q4 2020 at 197 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #870.

Winslow Evans & Crocker first reported a position in ARNA in Q1 2017 and has held it in 16 quarters since. 254 funds tracked by Wall St. Rank hold ARNA as of Q4 2020.

Winslow Evans & Crocker held 197 shares of Arena Pharmaceuticals Inc worth $15K as of Q4 2020.
Winslow Evans & Crocker left its Arena Pharmaceuticals Inc share count unchanged in Q4 2020.
Arena Pharmaceuticals Inc made up ﹤0.01% of Winslow Evans & Crocker's portfolio in Q4 2020, its #870 holding.
Winslow Evans & Crocker first reported a position in Arena Pharmaceuticals Inc in Q1 2017 and has held it in 16 quarters since.
254 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.